XCURMICRO

Exicure, Inc.

HealthcareBiotechnology
$2.20
$0.00(-12.00%)
52W$1.71
$9.50
Updated Jun 30, 02:00 AM
RSI41
RS Rating10/99
Beta0.93
Volatility115%
F-Score2/9
Mkt Cap$14M
DOWNTREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

DOWNTREND

Exicure, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 10), showing significant lag compared to the market leaders. Earnings contraction of 159% provides fundamental context to the price action. Investors should exercise caution due to high volatility (115% annualized), which requires wider risk management.

Relative Strength
10
out of 99
Lagging
Trend Score
0/4
Minervini Criteria
DOWNTREND
Risk (Beta)
0.93
vs S&P 500
MARKET
52W Position
6%
from 52W low
Near Low
Trend & Momentum Analysis

Trend Template (Minervini)

DOWNTREND0/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$3.05
50 SMA > 100 SMA$3.57
100 SMA > 150 SMA$4.20
150 SMA > 200 SMA$4.21

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$2.74-19.62%BELOW
50 SMA$3.05-27.82%BELOW
100 SMA$3.57-38.29%BELOW
150 SMA$4.20-47.56%BELOW
200 SMA$4.21-47.79%BELOW

Price Performance

1D-12.0%
1W-19.7%
1M-31.0%
3M-50.8%
6M-59.8%
YTD-60.6%
1Y-68.8%
3Y-32.7%
52-Week Trading Range6% from low
$2.20
52W Low$1.71
52W High$9.50

Technical Indicators

RSI (14)NEUTRAL
41.1
305070
Setup ScoreCOOL
1/10
Base depth: 118.6%

Risk Profile

Beta
0.93
52W Vol
115%
ATR
$0.37
Max DD (1Y)
-76%

Volume Analysis

Today
46.1K
50D Avg
25.8K
Vol Ratio
1.79x
Liquidity
ILLIQUID

Earnings Momentum

Q2'25-491%
$-0.41
Q3'25-160%
$-0.39
Q4'25+62%
$-0.45
Q1'26-159%
$-0.29
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth

10 Years:+22.45%
5 Years:
3 Years:
TTM:-67.50%

Stock Price CAGR

10 Years:-41.45%
5 Years:-60.52%
3 Years:-32.71%
1 Year:-68.75%

Return on Equity

10Y Avg:-113.3%
5Y Avg:-135.0%
3Y Avg:-159.6%
Last Year:-179.4%

Key Metrics

Market Cap$14M
Gross Margin
Net Margin
Piotroski F-Score2/9

Frequently Asked Questions

Is XCUR in an uptrend right now?

XCUR has a trend score of 0/4 based on Minervini's Stage Analysis. Currently showing broken structure - 0 of 4 trend criteria are met.

Is XCUR overbought or oversold?

XCUR's RSI (14) is 41. The stock is in neutral territory, neither overbought nor oversold.

Is XCUR outperforming the market?

XCUR has a Relative Strength (RS) Rating of 10 out of 99. XCUR is currently lagging the broader market.

Where is XCUR in its 52-week range?

XCUR is trading at $2.20, which is 23% of its 52-week high ($9.50) and 6% above its 52-week low ($1.71).

How volatile is XCUR?

XCUR has a Beta of 0.93 and 52-week volatility of 115%. It's less volatile than the S&P 500 - generally more stable.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.